Grant: Engage Grants Program
Simon Fraser University
$25,000.00
Structural analysis of small molecule inhibitors of a novel target for the treatment of cancer
EF 2012-13
Résumé
Cancer is a worldwide health problem and is the leading cause of death in Canada. Novel treatment strategies
are constantly being sought. Compared to normal cells, cancer cells exhibit aberrant metabolism characterized
by increased glucose uptake and rapid growth. The collaboration between Alectos Therapeutics and the Craig
group at SFU aims to characterize a series of small-molecule drug candidates that possess the ability to
selectively disrupt tumour metabolism. This proposed ENGAGE project will capitalize on the unique protein
biochemistry, structural modeling and crystallization capabilities of the Craig group at SFU. Using a
collaborative approach, Alectos and the Craig group will optimize the lead compounds for potency and
selectivity using protein crystallography and molecular modeling techniques. The success of this project may
lead to a better understanding of cancer cell metabolism and ultimately, a new treatment for cancer.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
429365-2012
Name nom
Craig, Lisa
Department département
Molecular Biology and Biochemistry
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5404
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Enzymes
Research subject fr
Enzymes
Partie
1
Nb partie
1
Application title
Structural analysis of small molecule inhibitors of a novel target for the treatment of cancer
Keyword
NSERC
Application summary
Cancer is a worldwide health problem and is the leading cause of death in Canada. Novel treatment strategies
are constantly being sought. Compared to normal cells, cancer cells exhibit aberrant metabolism characterized
by increased glucose uptake and rapid growth. The collaboration between Alectos Therapeutics and the Craig
group at SFU aims to characterize a series of small-molecule drug candidates that possess the ability to
selectively disrupt tumour metabolism. This proposed ENGAGE project will capitalize on the unique protein
biochemistry, structural modeling and crystallization capabilities of the Craig group at SFU. Using a
collaborative approach, Alectos and the Craig group will optimize the lead compounds for potency and
selectivity using protein crystallography and molecular modeling techniques. The success of this project may
lead to a better understanding of cancer cell metabolism and ultimately, a new treatment for cancer.